Remove 2019 Remove Clinic Remove Engineering Remove Individual
article thumbnail

Mastering Responses to FDA 510(k) AI Letters: A Strategic Approach

FDA Law Blog

Performance Metric FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 Average Number of FDA Days to MDUFA IV Decision 72.62 if additional testing is required or justification would suffice), responsible individuals, proposed timelines, and any clarifying questions for FDA. Average Number of Industry Days to MDUFA IV Decision 54.69

article thumbnail

Preemies receive sucrose for pain relief—new research shows it doesn't stop long-term impacts on development

Medical Xpress

Long-term effects of pain in early life We collected data on the number of procedures, clinical exposures and sucrose doses from three NICUs across Canada. However, we do not guarantee individual replies due to the high volume of messages. One of these sites does not use sucrose for acute pain management.

IT 53